REVOLUTION MEDICINES, INC. (RVMDW)
GOLDSMITH MARK A 🟡 adjusted position in 120.0K shares (2 derivative) of Revolution Medicines, Inc. (RVMD) at $150.09 ($19.1M) Transaction Date: Apr 15, 2026 | Filing ID: 000146
GOLDSMITH MARK A 🟡 adjusted position in 120.0K shares (2 derivative) of Revolution Medicines, Inc. (RVMD) at $150.09 ($19.1M) Transaction Date: Apr 15, 2026 | Filing ID: 000146
🔍 GOLDSMITH MARK A (Executive)
Company: Revolution Medicines, Inc. (RVMD)
Report Date: 2026-04-15
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 299,942.00 | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 396,698.00 | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 276,698.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
Date: 2026-04-15 | Code: H | nature_of_ownership: Trust | shares_owned_after: 594,060.00 | Footnotes: F4
Date: 2026-04-15 | Code: H | nature_of_ownership: Trust | shares_owned_after: 64,424.00 | Footnotes: F5
Date: 2026-04-15 | Code: H | nature_of_ownership: Trust | shares_owned_after: 64,424.00 | Footnotes: F6
Date: 2026-04-15 | Code: M | Expires: 2029-03-12 | Exercise: 2023-03-13 | equity_swap_involved: 0 | shares_owned_after: 24,464.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-04-15 | Code: M | Expires: 2029-08-08 | Exercise: 2023-08-09 | equity_swap_involved: 0 | shares_owned_after: 424,085.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes: